NCT07138222View on ClinicalTrials.gov

IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Melanoma (Skin Cancer)
Trial Locations (6)

2065

Melanoma Institute Australia, Sydney

3000

Peter MacCallum Cancer Centre, Melbourne

3004

The Alfred Hospital, Melbourne

3084

Austin Hospital, Melbourne

4102

Princess Alexandra Hospital, Brisbane

4870

Cairns Base Hospital, Cairns

All Listed Sponsors
lead

Peter MacCallum Cancer Centre, Australia

OTHER